Kisqali (ribociclib) - Novartis
Ibrance (palbociclib) - Pfizer
Verzenio (abemaciclib) - Eli Lilly
http://clinicaltrials.gov/ct2/show/NCT06959979
 
Sep 3, 2026
 
Prev Next